JP4808363B2 - 新規ポリペプチド及びこれを含む抗ｈｉｖ剤 - Google Patents

新規ポリペプチド及びこれを含む抗ｈｉｖ剤 Download PDF

Info

Publication number: JP4808363B2
Authority: JP; Japan
Prior art keywords: residue; polypeptide; citrulline; alanine; arginine
Prior art date: 2000-09-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2002525180A

Other languages

English (en)

Japanese (ja)

Other versions

JPWO2002020561A1 (ja

Inventor

信孝藤井

Original Assignee

バイオカインセラピューティックスリミテッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2001-09-05

Publication date

2011-11-02

2001-09-05 Application filed by バイオカインセラピューティックスリミテッド filed Critical バイオカインセラピューティックスリミテッド

2001-09-05 Priority to JP2002525180A priority Critical patent/JP4808363B2/ja

2004-01-15 Publication of JPWO2002020561A1 publication Critical patent/JPWO2002020561A1/ja

2011-11-02 Application granted granted Critical

2011-11-02 Publication of JP4808363B2 publication Critical patent/JP4808363B2/ja

2021-09-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/857—Fish; fish eggs; shell fish; crustacea

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Insects & Arthropods (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

JP2002525180A 2000-09-05 2001-09-05 新規ポリペプチド及びこれを含む抗ｈｉｖ剤 Expired - Fee Related JP4808363B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2002525180A JP4808363B2 (ja)	2000-09-05	2001-09-05	新規ポリペプチド及びこれを含む抗ｈｉｖ剤

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
JP2000269296		2000-09-05
JP2000269296		2000-09-05
JP2001092306		2001-03-28
JP2001092306		2001-03-28
JP2002525180A JP4808363B2 (ja)	2000-09-05	2001-09-05	新規ポリペプチド及びこれを含む抗ｈｉｖ剤
PCT/JP2001/007668 WO2002020561A1 (fr)	2000-09-05	2001-09-05	Nouveaux polypeptides et medicaments anti-vih contenant lesdits polypeptides

Publications (2)

Publication Number	Publication Date
JPWO2002020561A1 JPWO2002020561A1 (ja)	2004-01-15
JP4808363B2 true JP4808363B2 (ja)	2011-11-02

Family

ID=26599311

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2002525180A Expired - Fee Related JP4808363B2 (ja)	2000-09-05	2001-09-05	新規ポリペプチド及びこれを含む抗ｈｉｖ剤

Country Status (8)

Country	Link
US (2)	US7138488B2 (fr)
EP (1)	EP1323730B1 (fr)
JP (1)	JP4808363B2 (fr)
AT (1)	ATE465170T1 (fr)
AU (1)	AU2001284419A1 (fr)
CA (1)	CA2421183C (fr)
DE (1)	DE60136373D1 (fr)
WO (1)	WO2002020561A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8435939B2 (en)	2000-09-05	2013-05-07	Biokine Therapeutics Ltd.	Polypeptide anti-HIV agent containing the same
JP4781621B2 (ja) *	2002-08-27	2011-09-28	バイオカインセラピューティックスリミテッド	Ｃｘｃｒ４拮抗薬およびその用途
AU2003261723A1 (en) *	2002-08-27	2004-03-19	Takeda Chemical Industries, Ltd.	Cxcr4 antagonist and use thereof
WO2006126188A2 (fr) *	2005-05-25	2006-11-30	Hadasit Medical Research Services And Development Ltd.	Antagonistes de cxcr4 pour la cicatrisation des blessures et la reepithelialisation
ES2842210T3 (es) *	2006-12-21	2021-07-13	Biokine Therapeutics Ltd	4F-benzoil-TN14003 para la movilización de células progenitoras hematopoyéticas con vistas al trasplante
JP5715622B2 (ja)	2009-06-14	2015-05-07	バイオカインセラピューティックスリミテッド	血小板レベルを増大させるためのペプチド療法
US20130303460A1 (en)	2011-01-10	2013-11-14	Biokine Therapeutics Ltd.	Peptides and compositions for the treatment of neuroectodermal derived tumors and retinoblastoma
US9439942B2 (en)	2012-04-24	2016-09-13	Biokine Therapeutics Ltd.	Peptides and use thereof in the treatment of large cell lung cancer
KR20150135432A (ko)	2013-03-24	2015-12-02	바이오카인 테라퓨틱스 리미티드	골수성 백혈병의 치료 방법
US20160243187A1 (en)	2013-10-31	2016-08-25	Biokine Therapeutics Ltd.	Methods of treating acute myeloid leukemia with a flt3 mutation
US20170042893A1 (en)	2014-02-03	2017-02-16	Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.	Use of casein kinase i inhibitors for depleting stem cells
EP3943098A3 (fr)	2015-07-16	2022-05-11	Biokine Therapeutics Ltd.	Compositions et procédés pour le traitement du cancer
US20180221393A1 (en)	2015-08-03	2018-08-09	Biokine Therapeutics Ltd.	Cxcr4 binding agents for treatment of diseases
CA3014530A1 (fr)	2016-02-23	2017-08-31	Biolinerx Ltd.	Methodes de traitement de la leucemie myeloide aigue
EP3856225A1 (fr)	2018-09-25	2021-08-04	BioLineRx Ltd.	Procédés de sélection d'un traitement contre un cancer associé aux récepteurs cxcr4
CN116802189A (zh)	2020-12-30	2023-09-22	百欧林纳克斯有限公司	制备肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69416824T2 (de)	1993-10-14	1999-07-08	Seikagaku Corp., Tokio/Tokyo	Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
AU762472B2 (en)	1998-03-13	2003-06-26	University Of British Columbia, The	Therapeutic chemokine receptor antagonists
AU2001236065A1 (en) *	2000-03-03	2001-09-12	Nobutaka Fujii	Antiviral compounds
AU2003261723A1 (en) *	2002-08-27	2004-03-19	Takeda Chemical Industries, Ltd.	Cxcr4 antagonist and use thereof

2001
- 2001-09-05 US US10/363,209 patent/US7138488B2/en not_active Expired - Lifetime
- 2001-09-05 WO PCT/JP2001/007668 patent/WO2002020561A1/fr active Application Filing
- 2001-09-05 JP JP2002525180A patent/JP4808363B2/ja not_active Expired - Fee Related
- 2001-09-05 AU AU2001284419A patent/AU2001284419A1/en not_active Abandoned
- 2001-09-05 CA CA2421183A patent/CA2421183C/fr not_active Expired - Lifetime
- 2001-09-05 DE DE60136373T patent/DE60136373D1/de not_active Expired - Lifetime
- 2001-09-05 AT AT01963414T patent/ATE465170T1/de not_active IP Right Cessation
- 2001-09-05 EP EP01963414A patent/EP1323730B1/fr not_active Expired - Lifetime
2006
- 2006-08-01 US US11/497,225 patent/US7595298B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US7138488B2 (en)	2006-11-21
EP1323730A1 (fr)	2003-07-02
US20060264605A1 (en)	2006-11-23
EP1323730B1 (fr)	2010-04-21
AU2001284419A1 (en)	2002-03-22
EP1323730A4 (fr)	2005-01-05
DE60136373D1 (de)	2008-12-11
ATE465170T1 (de)	2010-05-15
US7595298B2 (en)	2009-09-29
CA2421183C (fr)	2015-06-16
WO2002020561A1 (fr)	2002-03-14
CA2421183A1 (fr)	2003-03-04
US20040116655A1 (en)	2004-06-17
JPWO2002020561A1 (ja)	2004-01-15

Legal Events

Date	Code	Title	Description
2003-06-23	A711	Notification of change in applicant	Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20030619
2003-07-24	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20030619
2005-02-23	A711	Notification of change in applicant	Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050222
2005-02-23	RD03	Notification of appointment of power of attorney	Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20050222
2005-03-24	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050222
2005-08-12	A711	Notification of change in applicant	Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20050714
2008-07-04	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080703
2008-07-11	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080703
2011-03-22	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110318
2011-06-21	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110620
2011-06-23	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110622
2011-06-28	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110627
2011-07-15	TRDD	Decision of grant or rejection written
2011-07-25	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110722
2011-07-28	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01
2011-08-25	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110817
2011-08-26	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20140826 Year of fee payment: 3
2011-08-26	R150	Certificate of patent or registration of utility model	Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 4808363 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2014-08-26	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2015-08-25	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2016-08-23	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2017-08-22	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2018-08-21	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2019-08-27	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2020-08-20	R250	Receipt of annual fees	Free format text: JAPANESE INTERMEDIATE CODE: R250
2021-08-26	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
US7595298B2 (en)	2009-09-29	Polypeptides having anti-HIV activity and compositions comprising same
JP3266311B2 (ja)	2002-03-18	新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
KR100208873B1 (ko)	1999-07-15	폴리펩타이드 및 그것으로 부터 제조된 항-hiv 제제
US8435939B2 (en)	2013-05-07	Polypeptide anti-HIV agent containing the same
US5571892A (en)	1996-11-05	Polypeptide and anti-HIV drug prepared therefrom
EP0267741B1 (fr)	1992-06-24	Composés peptidiques
HU211251A9 (en)	1995-11-28	Polypeptides with affinity to lipopolysaccharides and their uses
JPS6041697A (ja)	1985-03-05	活性蛋白質誘導体の新規合成法
Fischer et al.	1971	Sequence of a segment of muscle glycogen phosphorylase containing the pyridoxal 5'-phosphate binding site
JP3654667B2 (ja)	2005-06-02	ポリペプチド、その製造法およびそれをコードするｄｎａ
FUJII et al.	1988	Studies on Peptides. CLX.: Synthesis of a 33-Residue Peptide Corresponding to the Entire Amino Acid Sequence of Human Cholecystokinin (hCCK-33)
JP4332618B2 (ja)	2009-09-16	抗ｈｉｖ剤
JPH10324700A (ja)	1998-12-08	新規抗ｈｉｖ複合体及び医薬組成物
JPH07252299A (ja)	1995-10-03	ヒルジン誘導体およびその製造方法
WO1998043995A1 (fr)	1998-10-08	Nouveaux complexes anti-vih et compositions medicamenteuses
JPH0925240A (ja)	1997-01-28	医薬組成物